Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.
Connor MP, Prathapa N, Frey NV, Gill SI, Hexner EO, Bruno XJ, Lai CE, Loren AW, Luger SM, Matthews AH, McCurdy SR, Perl AE, Porter DL, Zeringue A, Oved JH, Olson TS, Pratz KW, Babushok DV. Connor MP, et al. Among authors: mccurdy sr. Haematologica. 2024 Apr 18. doi: 10.3324/haematol.2024.285275. Online ahead of print. Haematologica. 2024. PMID: 38634143 Free article.
Data resource profile: COVid VAXines effects on the aged (COVVAXAGE).
Hayes KN, Harris DA, Zullo AR, Djibo DA, Smith-Ray RL, Taitel MS, Singh TG, McMahill-Walraven C, Chachlani P, Wen KJ, McCarthy EP, Gravenstein S, McCurdy S, Baird KE, Moran D, Fenson D, Deng Y, Mor V. Hayes KN, et al. Among authors: mccurdy s. Int J Popul Data Sci. 2023 Oct 16;8(6):2170. doi: 10.23889/ijpds.v8i6.2170. eCollection 2023. Int J Popul Data Sci. 2023. PMID: 38425722 Free PMC article.
A US payer perspective health economic model assessing value of monitoring disease activity to inform discontinuation and re-initiation of DMT in multiple sclerosis.
Jalaleddini K, Bermel RA, Talente B, Weinstein D, Qureshi F, Rasmussen M, Menon S, Amarapala M, Jordan K, Ghoreyshi A, McCurdy S, Edgeworth M. Jalaleddini K, et al. Among authors: mccurdy s. Mult Scler. 2024 Mar;30(3):432-442. doi: 10.1177/13524585241227372. Epub 2024 Feb 19. Mult Scler. 2024. PMID: 38374525
Preconditioning Frailty Phenotype Influences Survival and Relapse for Older Allogeneic Transplantation Recipients.
Sung AD, Koll T, Gier SH, Racioppi A, White G, Lew M, Free M, Agarwal P, Bohannon LM, Johnson EJ, Selvan B, Babushok DV, Frey NV, Gill SI, Hexner EO, Martin M, Perl AE, Pratz KW, Luger SM, Chao NJ, Fisher AL, Stadtmauer EA, Porter DL, Loren AW, Bhatt VR, Gimotty PA, McCurdy SR. Sung AD, et al. Among authors: mccurdy sr. Transplant Cell Ther. 2024 Apr;30(4):415.e1-415.e16. doi: 10.1016/j.jtct.2024.01.062. Epub 2024 Jan 17. Transplant Cell Ther. 2024. PMID: 38242440
Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis.
Jalaleddini K, Jakimovski D, Keshavan A, McCurdy S, Leyden K, Qureshi F, Ghoreyshi A, Bergsland N, Dwyer MG, Ramanathan M, Weinstock-Guttman B, Benedict RH, Zivadinov R. Jalaleddini K, et al. Among authors: mccurdy s. Ann Clin Transl Neurol. 2024 Mar;11(3):729-743. doi: 10.1002/acn3.51996. Epub 2024 Jan 17. Ann Clin Transl Neurol. 2024. PMID: 38234075 Free PMC article.
326 results